TapewireFind a company

person · Reporting owner

Norstrud Andrew James

Disclosed activity across 2 companies

Tapewire entity
29470
SEC CIK
0001311402

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
UPEXI, INC.UPXI · Entity 6954Director · Chief Financial OfficerJuly 03, 2026July 20, 2026
nDivision Inc.NDVN · Entity 127466Director · CFODecember 22, 2021December 28, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

UPEXI, INC.

Report date July 03, 2026 · Filed July 20, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,049,138 Reported balance After 2026-07-03 transaction · row 1
1 source row

Row 1 · 2026-07-03 · Grant · Acquired 400,000 · Balance 1,049,138

F1: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service.

nDivision Inc.

Report date December 22, 2021 · Filed December 28, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.19 · Expires 2031-12-22Direct420,000 Reported balance After 2021-12-22 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2021-12-22 · Other · Acquired 100,000 · Balance 420,000

F1: The common stock options were granted to the reporting person pursuant to the nDivision Inc. Amended and Restated 2018 Equity Incentive Plan.

F2: The common stock options are fully vested upon their grant.

F3: Subject to earlier expiration upon termination of the reporting person's service with the Company, as described in the option agreement for the grant of the common stock options.

Filing footnotes · ownership attribution and instrument terms

F1: The common stock options were granted to the reporting person pursuant to the nDivision Inc. Amended and Restated 2018 Equity Incentive Plan.

F2: The common stock options are fully vested upon their grant.

F3: Subject to earlier expiration upon termination of the reporting person's service with the Company, as described in the option agreement for the grant of the common stock options.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 03, 2026 Filed Jul 20, 2026 21:27 UTC UPEXI, INC. UPXI · Entity 6954 GrantCommon Stock 400,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-26-004399 · form4.xml · nonDerivative · entry 1

Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,049,138

F1 · shares: Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal installments on October 1, 2026, January 1, 2027, April 1, 2027 and July 1, 2027, subject to continued service.

Read SEC document
October 01, 2025 Filed Nov 21, 2025 11:32 UTC UPEXI, INC. UPXI · Entity 6954 GrantCommon Stock 240,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-25-008534 · form4.xml · nonDerivative · entry 1

Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

F1 · shares: Vests quarterly in equal installments over 12 months beginning October 1, 2026.

F2 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

Read SEC document
July 16, 2025 Filed Jul 24, 2025 20:02 UTC UPEXI, INC. UPXI · Entity 6954 GrantCommon Stock 250,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-25-005235 · form4.xml · nonDerivative · entry 1

Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,138

F1 · shares: Vests monthly in equal installments over 12 months beginning July 1, 2025.

F2 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

Read SEC document
April 17, 2025 Filed Apr 25, 2025 20:01 UTC UPEXI, INC. UPXI · Entity 6954 GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-25-002980 · form4.xml · nonDerivative · entry 2

Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159,138

F2 · kind: This award of the Shares is being made pursuant to the Issuer's Restricted Stock Award Agreement, subject to the following vesting schedule: 10,000 Shares vest per month over a period of 10 months commencing April 17, 2025. A portion of all of this award may be forfeited in the event of termination of employment.

Read SEC document
April 17, 2025 Filed Apr 25, 2025 20:01 UTC UPEXI, INC. UPXI · Entity 6954 PurchaseCommon Stock 43,860 $2.28 $100,000.80
Disclosure

SEC source: 0001477932-25-002980 · form4.xml · nonDerivative · entry 1

Norstrud Andrew James · CIK 0001311402 · Director · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,138

F1 · shares: The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer. The shares are restricted securities subject to transfer restrictions under Rule 144 of the Securities Act until such time that they are registered pursuant to a registration statement or become eligible for resale otherwise.

Read SEC document
December 22, 2021 Filed Dec 28, 2021 21:31 UTC nDivision Inc. NDVN · Entity 127466 OtherCommon Stock Options · Derivative 100,000 $0.19 Strike: $0.19 $19,000.00
Disclosure

SEC source: 0001477932-21-009512 · form4.xml · derivative · entry 1

Norstrud Andrew James · CIK 0001311402 · Director · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,000

Underlying: Common Stock · 100,000 shares

Expires 2031-12-22

F1 · kind: The common stock options were granted to the reporting person pursuant to the nDivision Inc. Amended and Restated 2018 Equity Incentive Plan.

F2 · derivative.exercise_date: The common stock options are fully vested upon their grant.

F3 · derivative.expiration_date: Subject to earlier expiration upon termination of the reporting person's service with the Company, as described in the option agreement for the grant of the common stock options.

Read SEC document
July 21, 2021 Filed Aug 30, 2021 23:11 UTC UPEXI, INC. GRVI · Entity 6954 GrantOption Grant · Derivative 200,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001279925-21-000005 · primary_doc.xml · derivative · entry 1

Norstrud Andrew James · CIK 0001311402 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F1 · derivative.exercise_price: 200,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

F1 · date: 200,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

F1 · price: 200,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

F1 · derivative.exercise_date: 200,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

F1 · derivative.expiration_date: 200,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

Read SEC document
August 22, 2018 Filed Apr 9, 2019 15:48 UTC nDivision Inc. NDVN · Entity 127466 GrantStock Option · Derivative 20,000 $0.63 Strike: $0.63 $12,500.00
Disclosure

SEC source: 0001311402-19-000002 · primary_doc.xml · derivative · entry 1

Norstrud Andrew James · CIK 0001311402 · Director · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,000

Underlying: Common Stock · 20,000 shares

Expires 2028-08-22

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.